Breakthrough in Cancer Treatment: FDA Approves IMDELLTRA for Small Cell Lung Cancer
IMDELLTRA Shows Promising Results in Clinical Trials, Offering Hope for Patients
Amgen to Host Investor Call on May 20, 2024
THOUSAND OAKS, Calif., May 16, 2024 /PRNewswire/ — Amgen (NASDAQ: AMGN) announced today that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for IMDELLTRA™, a therapy for adult patients with extensive-stage small cell lung cancer (ES-SCLC) who have progressed after platinum-based chemotherapy. The approval is based on positive response rates and duration of response observed in clinical trials.
IMDELLTRA™ is the first and only DLL3-targeting therapy that activates the patient’s T cells to attack tumor cells expressing DLL3. This innovative treatment has shown impressive results in patients with ES-SCLC, offering a much-needed option for those in urgent need of effective therapies.
Leading experts in the field have praised the approval of IMDELLTRA, highlighting its potential to transform the treatment landscape for SCLC. The FDA approval is a significant milestone for the SCLC community, bringing new possibilities to those affected by this aggressive form of cancer.
For more information on this groundbreaking therapy and its potential impact, you can access the full interactive news release here.
“This approval marks a pivotal moment for patients battling ES-SCLC, providing a new innovative option for their treatment,” said Dr. Jay Bradner, Executive Vice President of Research and Development at Amgen. “We are committed to addressing aggressive cancers, and this FDA approval underscores our dedication to delivering effective treatments to those in need.”
Amgen will be hosting an investor call on May 20, 2024, to discuss the FDA approval of IMDELLTRA. This call will provide insights into the potential impact of this approval on the market and future developments in cancer treatment.
Contact:
Elissa Snook, 609-251-1407 (media)
Justin Claeys, 805-313-9775 (investors)
Vocabulary List:
- Breakthrough (noun): A significant development or achievement.
- Approval (noun): The action of officially agreeing to something or accepting it.
- Promising (adjective): Showing signs of future success or excellence.
- Therapy (noun): Treatment intended to relieve or heal a disorder.
- Accelerated (adjective): Increased in rateamountor extent.
- Innovative (adjective): Introducing new ideas original and creative in thinking.
